Education
About Us
Working with TipRanks
Follow Us
Mosaic Immunoengineering Inc (CPMV)
:CPMV
CPMV Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.12 - $1.13
Previous CloseN/A
Volume102.00
Average Volume (3M)468.00
Market Cap
$1.97M
Enterprise ValueN/A
Total Cash (Recent Filing)$252.90K
Total Debt (Recent Filing)$1.30M
Price to Earnings (P/E)―
Beta-0.68
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.13
Shares Outstanding7,242,137
10 Day Avg. Volume593
30 Day Avg. Volume468
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Mosaic ImmunoEngineering News
PremiumCompany Announcements
Mosaic ImmunoEngineering Delays 10-Q Filing
PremiumCompany Announcements
Mosaic ImmunoEngineering Delays Annual Report Filing
PremiumCompany Announcements
Mosaic ImmunoEngineering CFO Shifts to Part-Time Role
PremiumCompany Announcements
Mosaic ImmunoEngineering’s Strategic Acquisition and Funding Deal
PremiumCompany Announcements
Mosaic ImmunoEngineering Mourns Board Member LossPremiumCompany Announcements
Mosaic ImmunoEngineering Weighs Options Amid Financial WoesOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
CPMV FAQ
What was Mosaic Immunoengineering Inc’s price range in the past 12 months?
Mosaic Immunoengineering Inc lowest stock price was $0.12 and its highest was $1.13 in the past 12 months.
What is Mosaic Immunoengineering Inc’s market cap?
Mosaic Immunoengineering Inc’s market cap is $1.97M.
When is Mosaic Immunoengineering Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Mosaic Immunoengineering Inc’s earnings last quarter?
Currently, no data Available
Is Mosaic Immunoengineering Inc overvalued?
According to Wall Street analysts Mosaic Immunoengineering Inc’s price is currently Overvalued.
Does Mosaic Immunoengineering Inc pay dividends?
Mosaic Immunoengineering Inc does not currently pay dividends.
What is Mosaic Immunoengineering Inc’s EPS estimate?
Mosaic Immunoengineering Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mosaic Immunoengineering Inc have?
Mosaic Immunoengineering Inc has 7,242,137 shares outstanding.
What happened to Mosaic Immunoengineering Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Mosaic Immunoengineering Inc?
Currently, no hedge funds are holding shares in CPMV
Company Description
Mosaic Immunoengineering Inc
Mosaic ImmunoEngineering Inc., a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. It offers MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in mice, dogs, and humans. The company was founded in 2020 and is based in Novato, California.
Technical Analysis
Xenetic Biosciences
―
180 Life Sciences
―
Silo Pharma
―
NLS Pharmaceutics
―
Klotho Neurosciences
―